NHS rolls out teplizumab immunotherapy to delay type 1 diabetes onset by three years
By
Jim Reed
Summary
The NHS is rolling out teplizumab, an immunotherapy drug that delays the onset of type 1 diabetes by an average of three years in children and adults. The drug, also known as Tzield, works by reprogramming the immune system to stop it attacking insulin-producing cells. It will be offered to patients aged eight and over with early-stage type 1 diabetes. The article highlights the story of Theo Sebastian-Jenkins, an eight-year-old diagnosed at age four, who was too young to qualify for the treatment. Clinical trials show the drug can provide families with valuable extra time before insulin dependence begins.
Source
bskyNHS rolls out teplizumab immunotherapy to delay type 1 diabetes onset by three yearsbbc.co.ukKey quotes
· 3 pulledThe immunotherpay can give children and adults three extra years before they need to use insulin.
Theo Sebastian-Jenkins, now eight, was diagnosed when he was four, after his parents took him to A&E – he had been feeling unusually tired at home, was constantly thirsty and had been losing weight.
At the time, he was too young to qualify for the new drug, which
You might also wanna read
Clinical Trial Finds Ozempic Reverses Biological Age by 3.1 Years
The diabetes drug Ozempic has shown significant anti-aging effects in a clinical trial, reversing biological age by an average of 3.1 years
trial.medpath.com·10mo ago10 out of 12 people cured in Type 1 Diabetes Study
Crispr-Edited Pancreatic Cells Successfully Transplanted in Type 1 Diabetes Patient for the First Time
For the first time, researchers have successfully implanted Crispr-edited pancreatic cells into a patient with type 1 diabetes. The gene-edi
wired.com·9mo ago
Pfizer's Early 1990s Decision to Abandon Promising GLP-1 Therapy Development
The article reveals previously untold history about early GLP-1 drug development in the late 1980s and early 1990s. The author was part of w
statnews.com·5mo ago
Personal Reflection on Using Proprietary Medical Devices for Diabetes Management
The article discusses the author's personal experience with diabetes and their difficult choice to use a proprietary continuous glucose moni
sfconservancy.org·5mo ago
Mattel Launches First Barbie Doll with Diabetes
Mattel introduces its first Barbie doll representing a person with Type 1 diabetes, aiming to promote inclusivity in their doll collection.
The Onion·11mo agoComments
Sign in to join the conversation.
No comments yet. Be the first.